Found 11 matching trials
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B.
PHASE3This trial is conducted in Asia, Europe and North America. The aim of the t...
Location
Children's Hospital Los Angeles - Endocrinology
Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B
PHASE1This trial is conducted in Europe, Japan and the United States of America (...
Location
Novo Nordisk Investigational Site
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
N/AThis study will collect information on side effects and how well Refixia/RE...
Status
Enrolling By Invitation
Location
AKH - Klin. Abt. f. Haematologie u. Haemostaseologie
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
N/AIn parallel with the growth of ATHN's clinical studies, the number of new t...
Location
Arizona Hemophilia and Thrombosis Treatment Center at Phoenix Children's Hospital
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
N/AThe purpose of this study is to collect data on adverse events from third p...
Status
Enrolling By Invitation
Location
PedNet Haemophilia Registry
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
PHASE3This trial is conducted globally. The aim of the trial is to investigate th...
Location
Miller Children's Hospital Long Beach
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
PHASE3This trial is conducted in Asia, Europe, Japan, North America and South Afr...
Location
Novo Nordisk Investigational Site
A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B
PHASE3The study investigates how well the medicine called nonacog beta pegol (N9-...
Location
Beijing Children's Hospital, Capital Medical University
A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B
PHASE1This trial is conducted in Europe and the United States of America. The aim...
Location
Novo Nordisk Investigational Site
Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients
PHASE3This trial is conducted in Africa, Asia, Europe, Japan and North America. T...
Location
Novo Nordisk Investigational Site